InvestorsHub Logo
Post# of 252038
Next 10
Followers 2
Posts 79
Boards Moderated 0
Alias Born 06/23/2014

Re: None

Saturday, 02/16/2019 6:55:39 AM

Saturday, February 16, 2019 6:55:39 AM

Post# of 252038
CALA: Updated Results from Phase 1 Study of Telaglenastat (CB-839) to be Presented at 2019 ASCO Genitourinary Cancer Symposium

link

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.